NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.320
-0.090 (-6.38%)
Jun 16, 2026, 2:19 PM EDT - Market open
NanoViricides Employees
NanoViricides had 7 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,155,856
Market Cap
30.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 7 | 0 | - |
| Jun 30, 2024 | 7 | 0 | - |
| Jun 30, 2023 | 7 | -10 | -58.82% |
| Jun 30, 2022 | 17 | 0 | - |
| Jun 30, 2021 | 17 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Evaxion | 46 |
| Senti Biosciences Holdings | 39 |
| Kyntra Bio | 34 |
| Daré Bioscience | 24 |
| ABVC BioPharma | 19 |
| NeuroSense Therapeutics | 17 |
| Serina Therapeutics | 16 |
NNVC News
- 21 hours ago - NanoViricides files to sell 1.33M shares of common stock for holders - TheFly
- 1 day ago - NanoViricides announces proposal approved by Pillar Committee in DRC - TheFly
- 1 day ago - As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola - NanoViricides Proposal is Approved by the Pillar Committee in DR Congo - Accesswire
- 8 days ago - NanoViricides proposes Phase II trial of NV-387 gummies in Ebola - TheFly
- 8 days ago - As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Features Over Antibodies - Accesswire
- 10 days ago - NanoViricides files $50M mixed securities shelf - TheFly
- 21 days ago - In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides - Accesswire
- 4 weeks ago - NanoViricides Announces Closing of ~$2 Million Registered Direct Offering - Accesswire